Document Detail


Intranasal midazolam for claustrophobia in MRI.
MedLine Citation:
PMID:  8227594     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors present their preliminary results using intranasal midazolam for claustrophobic MRI patients. This route of administration reduced the necessity for intravenous sedation from 67 to 17% in this select group of patients. The only side effect encountered was a burning sensation of the nasal mucosa. Further investigation is necessary to determine the efficacy of intranasal midazolam in claustrophobic patients scheduled for MR examinations.
Authors:
M L Moss; P A Buongiorno; V A Clancy
Related Documents :
6740254 - Primary treatment of 50 patients with high-tension electrical injuries. i. fluid resusc...
16451284 - Do patients prescribed short-burst oxygen therapy meet criteria for ambulatory oxygen?
20965664 - Rhabdomyolysis and acute renal failure in severely burned patients.
15127194 - Body temperature alterations in the critically ill.
8839214 - Elevated amylase is related to the development of respiratory failure in organophosphat...
2869594 - Assessment and management of asthma in an accident and emergency department.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of computer assisted tomography     Volume:  17     ISSN:  0363-8715     ISO Abbreviation:  J Comput Assist Tomogr     Publication Date:    1993 Nov-Dec
Date Detail:
Created Date:  1993-12-01     Completed Date:  1993-12-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7703942     Medline TA:  J Comput Assist Tomogr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  991-2     Citation Subset:  IM    
Affiliation:
Department of Radiology, Fair Oaks Hospital, Fairfax, VA 22033.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Conscious Sedation
Humans
Magnetic Resonance Imaging* / psychology
Midazolam / administration & dosage*
Phobic Disorders / drug therapy*,  etiology
Chemical
Reg. No./Substance:
59467-70-8/Midazolam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SVC syndrome as a late complication of ascending aortic aneurysm repair: MR diagnosis.
Next Document:  PC-based multiparameter full-color display for tissue segmentation in MRI of adnexal masses.